Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs Midazolam for Bronchoscopy Sedation
NCT05994547Phase 4Completed
- Sponsor
- Chungbuk National University Hospital
- Start
- Apr 2022
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam (2 arms), sponsored by Chungbuk National University Hospital. Primary endpoints: Time from the end of the procedure to full alertness at 2 hours and Time taken to reach peak sedation at 30 minutes. Started Apr 2022; status: completed.
02
Drugs
remimazolam
Beyond the preview
Go deeper on NCT05994547.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05994547.